Loading viewer...
report
Format: PDF report
Billerud's interim report for Q1 2023 highlights financial performance amidst challenges like high input costs and a blastomycosis outbreak at the Escanaba mill.
presentation
report
BLOC 83
report
Triple Canopy
report
Cyclo Therapeutics
report
Sabra Hummus